Survival of the Oldest-Old: Allogeneic Transplantation Above 75 Years of Age

Key Points

• Survival improves with allogeneic transplantation in patients over 75 years old, showing significant clinical benefits.
• The 5-year survival rate reached 60% among older patients receiving transplants, highlighting effective treatment parameters.
• Assessment involved retrospective data collection spanning multiple centers, focusing on over 500 participants aged 75 and older.
• Findings support the consideration of allogeneic transplantation as a treatment option for the oldest-old, with further studies needed for validation.